Abstract
We demonstrate that doping hydroxyapatite (HAp) with Cr3+ ions induces oxygen vacancies, contributing to paramagnetism. Cathodoluminescence and photoluminescence analyses reveal increased oxygen vacancy formation in \({\text{O}}{\text{H}}^{-}\) and \({\text{P}}{\text{O}}_{4}^{3-}\) groups with rising Cr3+ concentrations, highlighted by stronger cathodoluminescence emissions at 2.57 and 2.95 eV and the photoluminescence emission at 3.32 eV. Raman spectroscopy shows new modes at 900 and 970 cm−1, indicating distortion of the v1 vibrational mode due to Cr3+ substitution at Ca(II) sites of the HAp lattice. X-ray photoelectron spectroscopy confirms Cr3+ in the HAp:Cr. Magnetometry reveals a shift from diamagnetism in pure HAp to increasing paramagnetism in HAp:Cr with higher Cr3+ content, achieving 0.0460 emu/g at 10 kOe with concentrations higher than 2.9 at.%. This paramagnetism is attributed to Cr3+ ions and singly ionized oxygen vacancies \(V^{\prime}_{{\text{O}}}\) aligning along an external magnetic field, with \(V^{\prime}_{{\text{O}}}\) formation linked to \({\text{PO}}_{4}^{{3}-}\) replacement by \({\text{PO}}_{3}^{{2}-}\) in HAp.
Similar content being viewed by others
Avoid common mistakes on your manuscript.
Introduction
Hydroxyapatite [Ca10(PO4)6(OH)2, HAp] is an essential biocompatible material used in orthopedics and dentistry, exhibiting excellent chemical similarity to the mineral components of bone and hard human tissue [1]. It has relevant applications in bone replacement technologies [2], bioactive coatings on metallic implants [3, 4] the design of drug and gene delivery agents [5], and as a dental material [6]. The crystal structure is hexagonal (space group P63/m) with an arrangement of Ca2+ and \({\text{P}}{\text{O}}_{4}^{3-}\) ions around \({\text{O}}{\text{H}}^{-}\) ion columns. The hexagonal unit cell contains ten calcium cations arranged in two non-equivalent positions. Four are located at the Ca(I) sites forming a channel surrounded by phosphates along the c-direction, and six are located at the Ca(II) sites, bound with \({\text{P}}{\text{O}}_{4}^{3-}\) ions and forming triangles staggered by 60° around the hydroxyl channel [7]. The relative abundance of these cations has been established as Ca(I)/Ca(II) = 2/3 [8, 9], making HAp a compound that lends itself to the incorporation of a range of cations by substituting into Ca2+ sites [10, 11]. These substitutions have emerged as an alternative approach to functionalize HAp, adding new luminescent and magnetic properties [12,13,14]. Some studies have focused on doping HAp with transition metal ions such as Mn2+, Co2+, Fe2+, and Fe3+, thus modifying the native diamagnetic behavior and obtaining a paramagnetic or superparamagnetic biomaterial [15,16,17].
Magnetic hydroxyapatite shows promising potential for applications in cancer theranostics, magnetic hyperthermia treatment, tissue engineering, bone regeneration, biosensors, and as contrast agents for magnetic resonance imaging [18]. Additionally, paramagnetic HAp is increasingly being explored for its utility as a green catalyst [19]. For instance, Campisi et al. [20] reported that HAp with Fe occupying Ca(II) sites could serve as an effective catalyst for reducing NOx emissions by ammonia. Similarly, Lu et al. [21] demonstrated that Fe-doped HAp exhibits outstanding performance in oxygen reduction reaction (ORR), suggesting its potential as a magnetic single-atom biological catalysts in biofuel cells and energy-related devices. Shi et al. [22] found that magnetic HAp enhances the catalytic detoxification of polycyclic aromatic hydrocarbons in fly ash. Furthermore, various studies have investigated how dopant percentages and HAp morphology influence catalytic activities across different reactions [23].
Recent advancements in catalysis and bone tissue engineering have focused on developing elongated one-dimensional (1D) HAp nanostructures such as tubes, wires, rods, ribbons, belts, and fibers owing to their large surface–area–to–volume ratios. The biological and catalytic activity of the HAp is highly influenced by its specific surface area [24], which enhances drug-loading capacities [25]. Notably, fibrous hydroxyapatite has garnered significant interest either as a self-reinforcement element or as a reinforcing component in biomedical composites, particularly in porous bone blocks and defect fillers [26]. Moreover, multifunctional HAp scaffolds based on paramagnetic HAp nanofibers have been engineered to influence bone growth through external magnetic fields [27]. Meng et al. [28] created a magnetic nanofibrous HAp scaffold incorporating γ-Fe2O3 superparamagnetic nanoparticles, which exhibits typical saturation magnetization values of 0.049 emu/g and promotes osteogenesis for bone repair in vivo. However, the safety of magnetic-responsive biomaterials is paramount for human applications. Thus, iron-based nanoparticles, known for their low cytotoxicity, are predominantly used in biomedical applications requiring magnetic stimulation [15, 29]. The selective incorporation of magnetic ions into the HAp lattice via ion exchange offers a promising approach to developing magnetic responsive HAp with minimal dopant concentrations while preserving its intrinsic biological properties [30].
Previously, we demonstrated the fabrication of luminescent and paramagnetic HAp through the selective incorporation of Fe3+ ions into HAp nanobelts, where the Fe3+ dopant substituted Ca(II) sites without inducing other oxidation states [31]. This selectivity in the oxidation state extends to other transition metals as well. For instance, Wakamura et al. [32] successfully incorporated Cr3+ into HAp nanostructures, noting morphology changes correlated with varying chromium concentrations. De Araujo et al. [33] also incorporated Cr3+ in HAp powders and confirmed the presence of dopant ions through characteristic absorption and emission bands. Moreover, Bangar et al. [34] conducted in vitro biological studies on Cr3+-doped HAp with HeLa and L929 cells, revealing a hemolytic ratio below 5% and affirming its biocompatibility with human blood for biomedical applications [35].
Cr3+ is recognized as an essential micronutrient vital for the human metabolism of proteins [36], characterized by low toxicity due to the poor solubility of its complexes at physiological pH levels, preventing cell membrane penetration [37]. In stark contrast, water-soluble Cr6+ ions pose significant health risks due to their structural similarity to phosphates, enabling their active transport into cells in place of anion \({\text{P}}{\text{O}}_{4}^{3-}\), leading to several outcomes including cancer and damage to the liver, kidney, respiratory, and immune systems [38, 39]. These health effects exclude the use of Cr6+ in biomedical applications and demand precise control in the chromium oxidation state that assures the exclusive presence of Cr3+ in a biomaterial. These adverse health effects necessitate stringent control over the chromium oxidation state in biomaterials, ensuring the exclusive presence of Cr3+ for safety.
To the best of our knowledge, the effect of chromium incorporation on the magnetic properties of hydroxyapatite, as well as the synthesis of elongated HAp:Cr nanostructures, have not been previously explored. This study presents the first evidence of paramagnetism in Cr3+-doped HAp nanofibers, demonstrating a magnetization saturation of 0.0460 emu/g at 10 kOe for Cr3+ concentrations exceeding 2.9 at.%. Our synthesis method achieves selective incorporation of Cr3+ into Ca(II) sites within the HAp lattice, leading to the formation of oxygen vacancies in \({\text{P}}{\text{O}}_{4}^{3-}\) groups and \({\text{O}}{\text{H}}^{-}\) groups. These vacancies become singly ionized, capturing electrons from Cr3+ ions within the HAp:Cr matrix. We suggest that these singly ionized oxygen vacancies act as spin ½ systems, thereby enhancing the paramagnetic response of the Cr3+ ions. Our findings position HAp:Cr as a promising candidate for bone regeneration treatments, offering potential for bone growth stimulation by magnetic fields and improved contrast in magnetic resonance imaging (MRI), which could significantly enhance diagnostic accuracy. Additionally, its versatility for theranostic applications in bone and tissue regeneration underscores the broad scope and potential utility of this biomaterial in the medical field.
Experimental Methodology
Hydroxyapatite nanofibers in powder form were prepared using a hydrothermal method described in our previous work [31, 40]. In brief, an aqueous solution (0.1 M) of di-ammonium phosphate [(NH4)2HPO4, Alfa Aesar, 11597-A1, CAS Number: 7783-28-0] was added drop-wise (1 drop per second) to a 0.1 M aqueous solution of calcium nitrate tetrahydrate [Ca(NO3)2⋅4H2O, 99%, Alfa Aesar, A16645-36, CAS Number: 13477-34-4] at a concentration of 0.2 M, previously heated under magnetic stirring in an electric heating mantle (Vakmo Tech, HMSC 250 mL) at a temperature of 100 °C. The calcium to phosphate (Ca/P) volume ratio of the precursor solutions was maintained at 1.667. After 48 h of stirring at 100 °C, the solution was cooled to room temperature. The HAp precipitate was collected by filtration and washed thoroughly with deionized water until the aqueous phase reached a pH of 7. Finally, the product was dried at 50 °C in an electric heating plate (Termolyne nuova HP18325) for 1 h under an air atmosphere.
For incorporation of the Cr3+ dopant ions, we used an ion-exchange procedure based by the following reaction:
in which three Ca2+ ions from the HAp lattice are substituted with two Cr3+ ions, resulting in one Ca2+ vacancy (\({\text{V}}_{\text{Ca}}\)). The chromium-exchange solution was prepared with chromium (III) nitrate nonahydrate [Cr(NO3)3⋅9H2O, 99.999%, Sigma Aldrich, 379972, CAS Number: 7789-02-8] at a concentration of 0.2 M. The previously synthesized HAp nanofibers were immersed in the chromium-exchange solution by mixing 0.5 g/dL and maintained under magnetic stirring at room temperature. The ion-exchange time was varied between 1, 12, 24, 36, and 48 h, to obtain five samples labeled HAp:Cr-1, HAp:Cr-12, HAp:Cr-24, HAp:Cr-36, and HAp:Cr-48, respectively. The powder samples were collected by filtration, washed until a pH of 7 was obtained, and dried at 50 °C for 1 h.
The crystalline structure of the powders was determined from X-ray powder diffraction (XRD) using a Philips X’pert MPD diffractometer operating at 30 kV and 10 mA with monochromatic CuKα radiation (λ = 0.15405 nm). The XRD spectra were recorded with Bragg- Brentano geometry in the range of 2θ from 20 to 70° with a step size of 0.02° and a second dwell per point. The vibrational modes of HAp were analyzed by Raman spectroscopy (Horiba Jobin–Yvon, LabRam HR800 micro-Raman system, Villeneuve d’Ascq, France), using a 633 nm He–Ne laser (Melles Griot, NY, USA) for excitation. An air-cooled charge-coupled device (CCD) detector was used to collect the scattered light dispersed by a 1600 lines/mm grating. The spectral resolution of the system used was 1.5 cm−1. For a systematic analysis, 0.5 g of each powder sample was deposited onto a silicon < 100 > wafer and flattened with a cover glass to obtain a homogeneous flat area, all Raman spectra were obtained with the 10 × Olympus objective (0.25 NA), which allows the measurements with a working distance of 10 mm to avoid the intense fluorescence of the hydroxyapatite. Raman spectra were collected and analyzed using the Labspec 5.0 software (Horiba, France, Labspec version 5.0) of the confocal microscope. To verify the correct operation of the spectrometer, the Raman spectra of well-known samples such as polypropylene and silicon were obtained and compared with reference ones. Furthermore, the LabRam HR800 micro-Raman system was used to acquire photoluminescence spectra from the samples in the 300–1100 nm spectral range, the same Raman measurements setup was used but changing the 325 nm line of a He-Cd laser and a 40 × UV objective (0.47 NA, Thorlabs, Newton, NJ, USA). An Oxford Instruments energy dispersive X-Max spectrometer (Abingdon, UK) with a detector size of 20 mm2, coupled to a JEOL JIB-4500 (Tokyo, Japan) scanning electron microscope (SEM), and the INCA X-Stream 2 (Oxford Instruments, Concord, MA, USA) were used to determine the elemental composition of the samples and to verify the presence of chromium in the HAp:Cr samples, as well as to quantify the Ca/P ratio. The powders were placed on double-sided conductive carbon tape mounted on the SEM holder. For each sample 10 EDS spectra were acquired at 15 keV with the No. 2 aperture (density current 38 A/m2) and 15 mm of work distance. Atomic percentage uncertainty of the detected elements corresponded to the standard deviation (sigma) of the INCA software calculation operated with a standards-based sequence. Hydroxyapatite (Ca10(PO4)6(OH)2) commercial powder sample (Sigma Aldrich, 900204, CAS Number: 1306-06-5) was used as a reference during the measurements to confirm the correct calibration of the EDS system, Ca, P and O concentrations were 43.5 (± 0.4), 26.1 (± 0.4) and 30.4 (± 0.7) atomic percent, respectively, and a Ca/P atomic relation of 1.67.
X-ray photoelectron (XPS) spectroscopy measurements were performed using a SPECS system with a PHOIBOS WAL analyzer and an aluminum anode. A 150 eV pass energy and 1 eV step size were used to acquire survey spectra. To determine the oxidation state of chromium, high-resolution XPS spectra of the Cr 2p peak were acquired using a pass energy of 50 eV and a step size of 0.1 eV. Narrow spectra were obtained using 300 scans during the measurement. The XPS spectra were calibrated by setting the C 1 s peak at 284.6 eV as a reference for the binding energy scale [41]. The sample morphology was analyzed using a field-emission scanning electron microscope (FE-SEM, FEI, Nova NanoSEM 200). Furthermore, the morphology was studied by a transmission electron microscope (TEM, JEOL, JEM 2200FS + CS), equipped with a field emission gun, working at an acceleration voltage of 200 kV and designed for high-resolution (HRTEM) imaging with a CEOS aberration corrector for the objective lens. Its ultimate point resolution in HRTEM mode is 1.0 Å. Additionally, the elements (Ca, P, O, and Cr) distribution was observed by TEM-EDS maps. For the TEM measurements 0.01 g of powder samples were dispersed into 10 ml of ethanol (JT Baker solution, Phillipsburg, NJ, USA) and systematically diluted until a transparent solution was obtained, then a drop of the sample was added onto a carbon-coated copper mesh grid. A Gatan MonoCL4 system (Pleasanton, CA, USA) equipped on the JEOL JIB-4500 SEM CL was used to obtain cathodoluminescence (CL) spectra in the visible range (200–800 nm). In addition, a vibrating sample magnetometer (VSM) attached to an Evercool-Physical Properties Measurement System (PPMS) from Quantum Design (San Diego, CA) was employed to determine the magnetic behavior of the HAp:Cr samples [42]. In brief, VSM works by placing a sample in a constant and uniform external magnetic field at a controlled temperature. As the magnetization in the vibrating sample increases, the induced current by the detector coils also increases. Therefore, the differences in current are translated by a computer as variations in the magnetization of the sample. Axial and radial sample positioning error introduces inaccuracy of the reported magnetic moment. Hence, this work was carried out considering the correct centering of the samples. First, the HAp:Cr powders were homogenized in an agate mortar, and then 0.005 g of sample mass was deposited inside the VSM Quantum Design powder sample holder (P125E,4096-388), which is an injection molded polypropylene (Formolene 4100N) plastic part that snaps into a brass half-tube Quantum Design sample holder (C130B) 4500-608, for a secure press fit. Then, the total length of the holder and the exact location of the sample were defined by using the PPMS-VSM Quantum Design mounting station. For all magnetic measurements, the sample was set in the middle of the polystyrene holder keeping the sample length less than 3 mm to maintain the accuracy of the point source dipole approximation. A 0.25 g cylindrical shape palladium standard sample with an expected moment of 0.01313 emu was used to calibrate the magnetometer at 1 Tesla and 298 K. The magnetization per unit mass (M, emu/g) measurements as a function of the applied magnetic field (H, Tesla) were performed for all the samples at 298 K, and the magnetic field was swept from 0 to 1 T, from 1 T to − 1 T, and again from − 1 T to 1 T.
Results and Discussion
The elemental composition of the as-synthesized HAp and HAp:Cr powders, obtained from energy dispersive spectroscopy (EDS) and listed in Table 1, show (Ca + Cr)/P ratios below 1.67 (stoichiometric value), suggesting that the HAp powders are calcium deficient. The Cr/Ca atomic ratio increases with increasing additions of chromium, confirming that chromium is incorporated into the HAp powders. Figure 1a–f illustrate the XRD patterns of the powders, where the diffraction peaks correspond to the hexagonal P63/m HAp structure (JCPDS card number 09-0432). The powders do not contain crystalline chromium oxide or metallic chromium impurity phases. Since EDS measurements reveal a calcium deficiency in all samples (see Table 1), we assume that the calcium-deficient (Ca-D) phase is present. However, identifying this phase is difficult because the HAp and Ca-D HAp structures display diffraction peaks at similar Bragg angles [43]. The XRD patterns also show that incorporating higher amounts of chromium decreases the crystalline quality of the HAp:Cr powders, as indicated by the broadening in the main diffraction peaks located at diffraction angles between 30 and 35° 2θ, most evident in the HAp:Cr-48 sample with a chromium concentration of 3.4 at.%.
Scanning electron micrographs obtained for the HAp:Cr-36 (Fig. 1g) and HAp:Cr-48 (Fig. 1h) powders show the formation of elongated nanostructures of varying lengths, and the transmission electron micrographs (Fig. 2) show widths between 50 and 100 nm. Elemental X-ray maps obtained for the HAp:Cr-48 powder show homogeneous signals for P (Fig. 3b), Cr (Fig. 3c), Ca (Fig. 3d), and O (Fig. 3e) along the nanofibers, confirming the uniform incorporation of chromium. Figure 4a, b illustrates high-resolution transmission electron micrographs along the [221] zone axis acquired for the HAp:Cr-36 and HAp:Cr-48 powders, respectively. The nanofibers exhibit a long axis in the [\(\stackrel{\text{-}}{1}\stackrel{\text{-}}{1}{\text{4}}\)] direction, which represents a tilt of only 7° from the [001] direction previously reported as the preferential growth direction of HAp nanofibers synthesized by the same method [31, 40]. Figure 4c, d are magnified images of the red squares in Fig. 4a, b, respectively, revealing a hexagonal array of atoms aligned along the [\(\stackrel{\text{-}}{1}\stackrel{\text{-}}{1}{\text{4}}\)], [\(\stackrel{\text{-}}{2}{\text{23}}\)], and [\(\stackrel{\text{-}}{2}{\text{1}}\stackrel{\text{-}}{2}\)] directions, with interatomic distances of 0.37 and 0.32 nm. These values agree with the a and b parameters of the ideal hexagonal HAp unit cell, modeled in Fig. 4e.
The chemical states of elements on the surfaces of the powders were analyzed using X-ray photoelectron spectroscopy (XPS). Figure 5 displays the survey XPS spectra, showing peaks for O 1 s, Ca 2p, and P 2p signals at approximately 532, 347, and 133 eV, respectively. For the HAp:Cr powders, Cr 2p doublet signals at 576 and 586 eV were also identified. Figure 6 presents the high-resolution spectra of the Cr 2p1/2 and 2p3/2 signals in HAp:Cr powders, which are centered at the binding energy values listed in Table 2. A notable energy difference of about 9.7 eV between these signals corresponds exclusively to the + 3 oxidation state of chromium [44]. This figure also illustrates that the intensity of the Cr 2p1/2 and 2p3/2 signals increases with the Cr-exchange time used during sample preparation, corresponding with the chromium concentration determined by EDS (Table 1). Table 2 summarizes the elemental compositions of the sample surfaces as calculated from the XPS results, showing slightly higher values than those obtained from EDS measurements (Table 1), a discrepancy due to the ion exchange process primarily occurring at the HAp surfaces.
High-resolution, deconvoluted XPS spectra of O 1 s, Ca 2p, P 2p, and Cr 2p signals for the HAp:Cr-48 sample are shown in Fig. 7. Figure 7a identifies components of the O 1 s signal at 531.6, 532.7, and 534.6 eV, corresponding to O–C bonds from atmospheric CO2, O–P and O–H bonds from phosphates and hydroxyl groups, and O–H2 bonds from adsorbed water, respectively [45]. Figure 7b displays the Ca 2p3/2 and 2p1/2 spin–orbit coupling signals at 347.8 and 351.3 eV, respectively, linked to Ca–PO3 bonds in the HAp lattice [46, 47]. The 2p3/2 and 2p1/2 components of the P 2p signal are shown in Fig. 7c, centered at 133.0 and 133.8 eV, respectively, consistent with the binding energy for P–O bonds in the HAp structure [48]. Lastly, Fig. 7d presents the 2p3/2 and 2p1/2 components of the Cr 2p signals, where the 2p3/2 signal has been deconvoluted using the multiplet-splitting components for Cr3+ reported by Biesinger et al. [49], at 575.7, 576.7, 577.5, 578.5, and 578.9 eV. These multiplets, generated by the exchange interaction between unpaired valence and core electrons during photoionization, definitively indicate the + 3 oxidation state of chromium. Complementing this, Lima et al. [50] used X-ray absorption near-edge structure (XANES) measurements to demonstrate that the valence of chromium ions in HAp changes from 3 + to + 6 when the chromium concentration exceeds 18 mol.% (5.5 at.%), a finding consistent with our XPS results as all our Cr-doped samples contained less than 4.4 at.% chromium (Table 2).
The Raman spectra of the HAp powders (Fig. 8) exhibit four characteristic vibrational signals centered at 430, 590, 962, and 1043 cm−1. The signals centered at 430 cm−1 (v2) and 590 cm−1 (v4) correspond to the O–P–O symmetric and asymmetric bending modes, respectively. The signals at 962 cm−1 (v1) and 1043 cm−1 (v3) correspond to the symmetric and asymmetric stretching vibration modes of P–O bonds, respectively [51, 52]. The weak signal centered at about 322 cm−1 corresponds to translational modes of the Ca2+ ions in the HAp lattice [53]. Raman spectra of the HAp:Cr powders reveal the same characteristic vibrational signals detected for HAp, but with the appearance of two signals at about 900 and 970 cm−1, which increase in intensity as the chromium concentration increases (arrows in Fig. 8). We propose that these signals correspond to vibrational modes related to the presence of Cr3+. Previously, Gomes et al. [54] reported that Zn incorporation in HAp induces a distortion of the phosphate tetrahedron in the vicinity of the incorporated Zn2+ ions, resulting in distortion of the v1 vibrational mode by the appearance of two signals around 958 and 968 cm−1, both of which increase in intensity as the Zn concentration in HAp is increased. Therefore, considering that the v1 vibrational mode represents the symmetrical stretching vibration of oxygen atoms around the phosphorus atoms in the PO4 groups, which are bound to Ca(II) ions in the HAp lattice, we postulate that the replacement of Ca(II) by Cr3+ ions generates the distortion of the v1 vibrational mode due to the charge imbalance generated. In addition, such charge imbalance produces calcium vacancies (\({\text{V}}_{\text{Ca}}\)) as a compensatory mechanism following Eq. (1), and as will be discussed later, also produces oxygen vacancies (\({\text{V}}_{\text{O}}\)) in the PO4 groups, which certainly modify the stretching vibration of the remaining oxygen atoms.
Cathodoluminescence (CL) measurements were used to evaluate the optical properties of the crystalline defects in the powders. Figure 9a illustrates the CL spectrum of the HAp nanofibers with seven components centered at 1.83, 2.15, 2.57, 2.95, 3.32, 3.67, and 4.05 eV, which we previously reported for HAp nanofibers, assigning an origin to native defects of hydroxyl vacancies (\({\text{V}}_{\text{OH}}\)) and oxygen vacancies (\({\text{V}}_{\text{O}}\)) in \({\text{O}}{\text{H}}^{-}\) and \({\text{P}}{\text{O}}_{4}^{3-}\) groups [31, 40]. Such components were calculated using Gaussian curves with a FWHM value of 0.4 eV to obtain values for the coefficient of determination, R2, between 0.9995 and 0.9999. Figure 9b–f display CL spectra obtained from the HAp:Cr powders, composed of the same seven components detected for HAp, revealing an increase in their panchromatic luminescence with chromium incorporation. This luminescence enhancement by the exclusive incorporation of Cr3+ ions in HAp demonstrates the feasibility of this biomaterial to be used as a luminescent marker in fluorescence microscopy and bioimaging during bone regeneration treatments, enabling the visualization of the implanted HAp interaction with the surrounding biological environment. CL measurements reveal additionally that the intensities of the 2.95 and 2.57 eV emissions increase more notably with Cr doping (Table 3). As illustrated in Fig. 10, the band at 2.57 eV corresponds to transitions between levels of hydroxyl vacancies next to an H+ interstitial (\({\text{V}}_{\text{OH}} \, - \, {\text{H}}_{\text{i}}\)) and \({\text{V}}_{\text{O}}\) in the \({\text{P}}{\text{O}}_{4}^{3-}\) groups [40, 55, 56], while the emission of 2.95 eV corresponds to transitions between energy levels generated by \({\text{V}}_{\text{OH}}\) and \({\text{V}}_{\text{O}}\) in the OH− groups [60]. The emission of 3.67 eV does not exhibit an increase in intensity with chromium doping (Table 3), even though this emission is generated by electronic transitions between the same energy levels of \({\text{V}}_{\text{OH}}\) that produce the 2.95 eV emission (Fig. 10). Thus, considering that the electronic capture cross-sectional area of point defects does not change by the incorporation of chromium in the HAp lattice, and that both emissions of 2.95 and 3.67 eV correspond to transitions between the same levels of \({\text{V}}_{\text{OH}}\), we infer that the increase of 2.95 eV emission can only be attributed to a rise in the density of electronic states associated with \({\text{V}}_{\text{O}}\) in the OH– groups. We estimated the proportion of oxygen vacancies in Cr-doped samples compared to the undoped HAp by calculating the intensity ratio of the 2.95 eV emission between the HAp:Cr and HAp samples (Table 3). Our findings show that the incorporation of Cr3+ ions into the HAp lattice increases the concentration of \({\text{V}}_{\text{O}}\) in the \({\text{O}}{\text{H}}^{-}\) groups by 1.2 and 2.5 times compared to undoped HAp. Previously, Bystrov et al. calculated the unit cell parameters and volume of HAp with one \({\text{V}}_{\text{O}}\) in the \({\text{O}}{\text{H}}^{-}\) group, reporting values of a = 9.3437 Å, c = 6.8463 Å, and V = 517.64 Å3 [57]. These were compared to stoichiometric HAp, which showed a = 9.3640 Å, c = 6.8621 Å, and V = 521.09 Å3. Given that one oxygen vacancy in a 44 atom HAp unit cell corresponds to a 2.2 at.% concentration (a relatively high concentration), the slight reduction in the a and c parameters and a similar unit cell volume, indicate the ability of the HAp structure to integrate oxygen vacancies with minimal distortion. This suggests a degree of flexibility withing the crystal structure, allowing for the incorporation of \({\text{V}}_{\text{O}}\) in the \({\text{O}}{\text{H}}^{-}\) group while maintaining overall geometry and ensuring structural stability. Furthermore, Bystrov et al. [58] also demonstrated that oxygen vacancies occur under equilibrium conditions in HAp as simple vacant oxygen sites with a neutral charge, and that the formation of \({\text{V}}_{\text{O}}\) in the \({\text{O}}{\text{H}}^{-}\) groups occurs by removal of neutral O from \({\text{O}}{\text{H}}^{-}\) leaving a hydride anion (\({\text{H}}^{-}\)). In addition, these authors report that oxygen vacancies generated in \({\text{O}}{\text{H}}^{-}\) groups exhibit lower formation energy than \({\text{V}}_{\text{O}}\) in \({\text{P}}{\text{O}}_{4}^{3-}\) groups. Therefore, to explain the generation of oxygen vacancies in the \({\text{O}}{\text{H}}^{-}\) groups of the HAp:Cr samples, we propose that during the ion-exchange process, pairs of extra electrons are generated by substituting Cr3+ with Ca2+ following the reaction:
Schematic representation of the electronic transitions for HAp [21]
Afterward, the two free electrons can be captured by neutral oxygen atoms that have been removed from \({\text{O}}{\text{H}}^{-}\) groups to form O2− ions in the aqueous solution and \({\text{V}}_{\text{O}}\) in the HAp lattice, as follows:
Here, the compound \({\text{Ca}}_{\left(\text{10-2}{\text{x}}\right)}{\text{Cr}}_{{2}{\text{x}}}{\left({\text{P}}{\text{O}}_{4}\right)}_{6}{\text{H}}\) represents the HAp with hydride anions (\({\text{H}}^{-}\)).
Figure 11a illustrates the photoluminescence (PL) spectrum obtained for the HAp powder with two broad primary emissions centered at 2.40 and 2.98 eV, which were deconvoluted using Gaussian curves with a FWHM value of 0.38 eV, and centered at 2.15, 2.40, 2.58, 2.98, and 3.31 eV. These components correspond well with the CL components shown in Fig. 9, except for the 2.40 eV band that corresponds to electronic transitions between levels generated by \({\text{V}}_{\text{Ca}}\) and \({\text{V}}_{\text{O}}\) in \({\text{P}}{\text{O}}_{4}^{3-}\) [60]. Figures 11b–f show the PL spectra obtained from the HAp:Cr powders, which were deconvoluted with the same components calculated for the HAp sample, and including the component of 1.85 eV detected by CL, which corresponds to electronic transitions from the HAp conduction band to levels generated by \({\text{V}}_{\text{OH}}\) [60]. Figures 11b–f reveal that the 3.31 eV band gradually increases in relative intensity by increasing the chromium concentration in the samples, which correlates with that observed for the 3.32 eV CL emission (Fig. 9b–f). Considering that this band corresponds to electronic transitions between the HAp conduction band and energy levels of \({\text{V}}_{\text{O}}\) in \({\text{P}}{\text{O}}_{4}^{3-}\) groups [60], the increase of the 3.31 eV emission must be associated with an increase in the amount of \({\text{V}}_{\text{O}}\) in \({\text{P}}{\text{O}}_{4}^{3-}\) in the doped samples.
The magnetic response of the materials was analyzed by applying magnetic fields of ± 10 kOe at room temperature. Figure 12 illustrates the magnetization (M) with respect to the applied magnetic field (H) for the powders. Line 1 corresponds to the magnetic response of the HAp powder, which exhibits a diamagnetic behavior in agreement with previous reports [17, 31, 59, 60], showing a value for the mass magnetic susceptibility (χ) of − 2.6 × 10–6 emu/Oe⋅g. In diamagnetic materials, atoms have an even number of electrons in the partially filled shells and do not exhibit a net magnetic moment without an external magnetic field. Under a magnetic field, the spins of these electrons experience a precession motion, producing a magnetization in the opposite direction to the external magnetic field, described by the Langevin theory [61]. We expect diamagnetism in undoped HAp because it contains even numbers of electrons in the atomic orbitals of Ca2+, \({\text{O}}{\text{H}}^{-}\), and \({\text{P}}{\text{O}}_{4}^{3-}\) ions. The HAp:Cr-1 sample also exhibits a diamagnetic behavior (line 2), although with a susceptibility of − 7.7 × 10–7 emu/Oe⋅g, representing a decrease compared to the value observed for the HAp powder. This effect is due to the generation of local paramagnetism at the atomic sites of Cr3+ ions, which partially inhibits the native diamagnetism of HAp. The origin of such local paramagnetism is the unpaired electrons of Cr3+ in the 3d orbitals. According to Hund’s rule, these electrons occupy separate orbitals with their spin parallel before pairing up, leading to three unpaired electrons in the 3d subshell. Each unpaired electron has a magnetic moment associated with its spin, and in the presence of a magnetic field, these magnetic moments can align with the field, minimizing the energy. Figure 12 also shows that the HAp:Cr-12 powder exhibits a positive susceptibility of 9.2 × 10–8 emu/Oe⋅g (line 3), corresponding to a weak paramagnetic behavior of the sample, due to the increase of unpaired electrons in the Cr3+ ions that entirely inhibit the native diamagnetism of undoped HAp. Additionally, Fig. 12 shows that the HAp:Cr-24, HAp:Cr-36, and HAp:Cr-48 powders (lines 4–6) exhibit paramagnetism with magnetic susceptibility values increasing with chromium doping (Table 4). Notably, these results do not reveal a magnetic transition to superparamagnetism, as other authors have reported for HAp nanoparticles doped with Fe at 0.7 at.%, which corresponds to a similar concentration of the magnetic impurity added to the HAp:Cr-24 sample [62], demonstrating the absence of magnetic domains within the HAp:Cr nanofibers. Previously, we had reported that undoped HAp nanofibers exhibit electron paramagnetic resonance (EPR) signals identifying the formation of singly ionized oxygen vacancies (\({\text{V}}_{\text{O}}{\prime}\)) acting as spin ½ systems due to the presence of one unpaired electron [40], with a magnetic moment, \({\mu }_{s}\), given by:
where gs is the Landé g-factor for the spin with a value of about 2.0023 for a free electron, and μB is the magneton of Bohr defined as \(e\hslash /2{m}_{e}\). Thus, intrinsic magnetic moments of \({\text{V}}_{\text{O}}{\prime}\) can align with an external magnetic field, resulting in a paramagnetic behavior by minimizing the energy. Since CL and PL results demonstrate that HAp:Cr samples contain the same point defects we reported for undoped HAp [21], we infer that singly ionized oxygen vacancies are also present in HAp:Cr powders. Furthermore, since the PL and CL results reveal a notable increase of oxygen vacancies in HAp with Cr3+ doping, we propose that the formation of \({\text{V}}_{\text{O}}{\prime}\) is highly probable in our samples. Previously, Bystrov et al. [58] demonstrated that the replacement of \({\text{PO}}_{4}^{{3}-}\) by \({\text{PO}}_{3}^{{2}-}\) anions produces stable singly charged oxygen vacancies, which they labeled as \({\text{V}}_{\text{O}}^{+}\) to highlight the + 1 charge state for substitution \({\left[{\text{P}}{\text{O}}_{3}^{{2}-}\right]}_{{\text{PO}}_{4}^{{3}-}}^{+}\). Considering the charge neutrality of the HAp, this chemical mechanism be described as follows:
where \({\text{V}}_{\text{O}}^{-}\) corresponds to a singly ionized oxygen vacancy, or \({\text{V}}_{\text{O}}{\prime}\) using Kröger-Vink notation. Equation (5) corresponds to the formation of \({\text{V}}_{\text{O}}\) in the \({\text{P}}{\text{O}}_{4}^{{3}-}\) groups, which alternatively can be rewritten considering that free electrons generated during the Cr3+ incorporation in HAp (see Eq. 2) can be trapped by \({\text{V}}_{\text{O}}\) forming singly ionized oxygen vacancies as follow:
Thus, we propose that the paramagnetic behavior of HAp:Cr is produced both by the unpaired 3d electrons of the Cr3+ ions and by the formation of \({\text{V}}_{\text{O}}{\prime}\). Table 4 lists the maximum magnetization (Mmax) and magnetic susceptibilities (χ of the HAp:Cr samples obtained for a magnetic field of 10 kOe, revealing a saturation magnetization of 0.0460 and 0.0470 emu/g for the HAp:Cr-36 and HAp:Cr-48 powders, respectively.
In summary, this study provides the first evidence of paramagnetism in hydroxyapatite (HAp) nanofibers doped with Cr3+ ions. The incorporation of Cr3+ leads to significant oxygen vacancy formation in \({\text{P}}{\text{O}}_{4}^{3-}\) and \({\text{O}}{\text{H}}^{-}\) groups. These vacancies become singly ionized, capturing electrons from Cr3+ ions within the HAp:Cr matrix. This mechanism underlies the observed paramagnetism, with HAp:Cr samples achieving saturation magnetization of 0.0460 emu/g at 10 kOe for Cr3+ concentrations above 2.9 at.%. We suggest that these singly ionized oxygen vacancies act as spin ½ systems, significantly enhancing the paramagnetic response of the Cr3+-doped HAp. This paramagnetic biomaterial is an exceptional candidate for bone regeneration treatments, offering potential applications for bone growth stimulation by magnetic fields and improved contrast in magnetic resonance imaging. Biocompatibility studies of HAp:Cr are still pending and are planned for future investigations.
Conclusions
Chromium-doped hydroxyapatite (HAp:Cr) nanofibers, synthesized via a modified hydrothermal method, exhibited a calcium deficiency and a hexagonal P63/m structure, with amorphization occurring at Cr concentrations exceeding 3.4 at.%. X-ray photoelectron spectroscopy confirmed Cr3+ substitution for Ca(II) within the HAp lattice. Raman spectroscopy detected standard HAp vibrational modes alongside new modes at 900 and 970 cm−1, intensified by increasing Cr content due to a Cr3+-induced v1 P–O bonds vibrational mode distortion. Cathodoluminescence indicated oxygen vacancy-related emissions at 2.95 and 2.57 eV, increasing with Cr concentration, suggesting generation of oxygen vacancies in hydroxyl groups. Photoluminescence also showed enhanced 3.32 eV emission with rising Cr doping, attributed to increased oxygen vacancies in \({\text{P}}{\text{O}}_{4}^{3-}\) groups. Vibrating sample magnetometry confirmed diamagnetism from pure HAp and generation of paramagnetism in HAp:Cr nanofibers, with chromium concentrations above 2.9 at.% reaching a magnetization saturation of 0.0460 emu/g at 10 kOe, attributable to the alignment of Cr3+ magnetic moments and singly ionized oxygen vacancies (\({\text{V}}_{\text{O}}{\prime}\)) acting as spin ½ systems. This paramagnetism is likely enhanced by the substitution of \({\text{PO}}_{4}^{{3}-}\) with \({\text{PO}}_{3}^{{2}-}\), leading to increased oxygen vacancies in the PO4 groups.
Data Availability
The datasets generated during the current study are available from the corresponding authors upon request.
References
F. Fendi, B. Abdullah, S. Suryani, A.N. Usman, D. Tahir, Development and application of hydroxyapatite-based scaffolds for bone tissue regeneration: a systematic literature review. Bone 183, 117075 (2024)
K.F. Tseng, S.T. Shiu, C.Y. Hung, Y.H. Chan, T.J. Chee, P.C. Huang, P.C. Lai, S.W. Feng, Osseointegration potential assessment of bone graft materials loaded with mesenchymal stem cells in peri-implant bone defects. Int. J. Mol. Sci. 25, 2–862 (2024)
R. Gómez, Z.S. Guzmán, K. Carrera, I. Leal, A. Hurtado, G. Herrera, V. Orozco, Impact evaluation of high energy ball milling homogenization process in the phase distribution of hydroxyapatite-barium titanate plasma spray biocoating. Coatings 11, 6–728 (2021)
B. Murphy, M.A. Morris, J. Baez, Development of hydroxyapatite coatings for orthopaedic implants from colloidal solutions: part 2-detailed characterisation of the coatings and their growth mechanism. Nanomaterials 13, 2577 (2023)
N. Safitri, N. Rauf, D. Tahir, Enhancing drug loading and release with hydroxyapatite nanoparticles for efficient drug delivery: a review synthesis methods, surface ion effects, and clinical prospects. J. Drug Deliv. Sci. Technol. 90, 105092 (2023)
A. Racic, D. Veljovic, Hydroxyapatite-based dental inserts Microstructure mechanical properties bonding efficiency and fracture resistance of molars with occlusal restorations. J. Biomed. Mater. Res. B Appl. Biomater. 112, 35331 (2024)
M. Aaddouz, K. Azzaoui, N. Akartasse, E. Mejdoubi, B. Hammouti, M. Taleb, R. Sabbahi, S.F. Alshahateet, Removal of methylene blue from aqueous solution by adsorption onto hydroxyapatite nanoparticles. J. Mol. Struct. 1288, 135807 (2023)
H. El Feki, J.M. Savariault, A. Ben Salah, Structure refinements by the Rietveld method of partially substituted hydroxyapatite: Ca9Na0.5(PO4)4.5(CO3)1.5(OH)2. J. Alloys Compds. 287, 114–120 (1999)
A. Bigi, E. Boanini, C. Capuccini, M. Gazzano, Strontium-substituted hydroxyapatite nanocrystals. Inorg. Chim. Acta 360, 1009–1016 (2007)
T. Ivankovic, H. Turk, J. Hrenovic, Z. Schauperl, M. Ivankovic, A. Ressler, Antibacterial activity of silver doped hydroxyapatite toward multidrug-resistant clinical isolates of Acinetobacter baumannii. J. Hazard. Mater. 458, 131867 (2023)
N.V. Petrakova, Y.O. Zobkova, V.S. Komlev, A.A. Ashmarin, A.S. Lysenkov, V.A. Volchenkova, S.M. Barinov, M.A. Sadovnikova, F.F. Murzakhanov, M.R. Gafurov, E.A. Kudryavtsev, S.S. Kozyukhin, A.L. Trigub, A.V. Rogachev, Synthesis and characterization of luminescent cerium-doped hydroxyapatite. Ceram. Int. (2024). https://doi.org/10.1016/j.ceramint.2024.03.093
L.A. Zavala, P. Fernández, E. Novitskaya, J.N. Díaz, M. Herrera, O.A. Graeve, Interconfigurational and intraconfigurational transitions of Yb2+ and Yb3+ ions in hydroxyapatite: a cathodoluminescence study. Acta Mater. 135, 35–43 (2017)
L.A. Zavala-Sanchez, G.A. Hirata, E. Novitskaya, K. Karandikar, M. Herrera, O.A. Graeve, Distribution of Eu2+ and Eu3+ Ions in hydroxyapatite: a cathodoluminescence and Raman study. ACS Biomater. Sci. Eng. 1, 1306–1313 (2015)
H. Inam, S. Sprio, M. Tavoni, Z. Abbas, F. Pupilli, A. Tampieri, Magnetic hydroxyapatite nanoparticles in regenerative medicine and nanomedicine. Int. J. Mol. Sci. (2024). https://doi.org/10.3390/ijms25052809
S. Balakrishnan, V.P. Padmanabhan, R. Kulandaivelu, T.S.N. Nellaiappan, S. Sagadevan, S. Paiman, F. Mohammad, H.A. Al-Lohedan, P.K. Obulapuram, W.C. Oh, Influence of iron doping towards the physicochemical and biological characteristics of hydroxyapatite. Ceram. Int. 47, 5061–5070 (2021)
E. Raudonyte-Svirbutaviciene, G. Klydziute, L. Lukaviciute, A. Antuzevics, A. Balciunaite, E. Norkus, A. Aldona Beganskiene, A. Zarkov, K. Aivaras, Hydrothermal synthesis of Mn2+-and Cu2+-doped calcium hydroxyapatite: morphological features and importance of EPR insights. Ceram. Int. 50, 4005–4013 (2024)
M.E. Zilm, M. Staruch, M. Jain, M. Wei, An intrinsically magnetic biomaterial with tunable magnetic properties. J. Mater. Chem. B. 2, 7176–7185 (2014)
A. Mushtaq, X. Ma, J. Farheen, X. Lin, M. Tayyab, M.Z. Iqbal, X. Kong, Facile synthesis of metformin loaded Mn3O4-HAp magnetic hydroxyapatite nanocomposites for T1-magnetic resonance imaging guided targeted chemo-phototherapy in vitro. Colloids Surf A Physicochem Eng Asp 674, 131911 (2023)
R. Corentin, T. Cyril, B. Dalil, Y. Millot, M. Antoine, C. Guylène, Surface immobilization mechanisms of cobalt ions on hydroxyapatite catalyst supports. Catal. Today 432, 114621 (2024)
S. Campisi, M. Galloni, S.G. Marchetti, A. Auroux, G. Postole, A. Gervasini, Functionalized iron hydroxyapatite as ecofriendly catalyst for NH3-SCR reaction: activity and role of iron speciation on the surface. ChemCatChem 12, 1676–1690 (2020)
Z. Lu, Y. Cheng, D. Ma, H. Liang, X. Wang, L. Yang, Z. Yang, Substitution of Fe in hydroxyapatite as an efficient single-atom catalyst for oxygen reduction reaction in biofuel cells: a first-principles study. Appl. Surf. Sci. 539, 148233 (2021)
D. Shi, J. Liu, H. Tong, K. Fu, M. Salam, J. Huang, S. Xu, X. Wen, H. Xie, P. Wang, H. Cai, D. Luo, Enhancement of catalytic detoxification of polycyclic aromatic hydrocarbons in fly ash from municipal solid waste incineration via magnetic hydroxyapatite-assisted hydrothermal treatment. Sci. Total. Environ. 918, 170467 (2024)
H. Yook, J. Hwang, W. Yeo, J. Bang, J. Kim, T.Y. Kim, J.S. Choi, J.W. Han, Design strategies for hydroxyapatite-based materials to Enhance their catalytic performance and applicability. Adv. Mater. 35, 202204938 (2023)
B. Li, J. Ren, X. Cheng, Y. He, P. Song, R. Wang, Hydroxyapatite nanowires-based Janus micro-rods for selective separation of organics. Colloids Surf A Physicochem Eng Asp 652, 129826 (2022)
S. Zhao, J. Ren, F. Zhang, Y. He, X. Han, R. Wang, Fabrication of nano-hammer shaped CuO@HApNWs for catalytic degradation of tetracycline. Environ. Res. 249, 118410 (2024)
S. Oshima, T. Sato, M. Honda, Y. Suetsugu, K. Ozeki, M. Kikuchi, Fabrication of gentamicin-loaded hydroxyapatite/collagen bone-like nanocomposite for anti-infection bone void fillers. Int. J. Mol. Sci. 21, 551 (2020)
S. Bettini, V. Bonfrate, L. Valli, G. Giancane, Paramagnetic functionalization of biocompatible scaffolds for biomedical applications: a perspective. Bioengineering 7, 1–31 (2020)
J. Meng, B. Xiao, Y. Zhang et al., Super-paramagnetic responsive nanofibrous scaffolds under static magnetic field enhance osteogenesis for bone repair in vivo. Sci. Rep. 3, 2655 (2013)
M.A. Goldberg, M.R. Gafurov, F.F. Murzakhanov, A.S. Fomin, O.S. Antonova, D.R. Khairutdinova, A.V. Pyataev, O.N. Makshakova, A.A. Konovalov, A.V. Leonov, S.A. Akhmedova, I.K. Sviridova, N.S. Sergeeva, S.M. Barinov, V.S. Komlev, Mesoporous iron(III)-doped hydroxyapatite nanopowders obtained via iron oxalate. Nanomaterials 11, 1–21 (2021)
B. Srinivasan, E. Kolanthai, E.A.K. Nivethaa, M.S. Pandian, P. Ramasamy, L.H. Catalani, S.H. Kalkura, Enhanced in vitro inhibition of MCF-7 and magnetic properties of cobalt incorporated calcium phosphate (HAp and β-TCP) nanoparticle. Ceram. Int. 49, 855–861 (2023)
K. Carrera, V. Huerta, V. Orozco, J. Matutes, P. Fernández, O.A. Graeve, M. Herrera, Formation of vacancy point-defects in hydroxyapatite nanobelts by selective incorporation of Fe3+ ions in Ca(II) sites A CL and XPS study. Mater. Sci. Eng. B Solid-State Mater. Adv. Technol. 271, 115308 (2021)
M. Wakamura, K. Kandori, T. Ishikawa, Influence of chromium(III) on the formation of calcium hydroxyapatite. Polyhedron 16, 2047–2053 (1997)
T.S. De Araujo, Z.S. MacEdo, P.A.S.C. De Oliveira, M.E.G. Valerio, Production and characterization of pure and Cr3+-doped hydroxyapatite for biomedical applications as fluorescent probes. J. Mater. Sci. 42, 2236–2243 (2007)
S.S. Bandgar, H.M. Yadav, S.S. Shirguppikar, M.A. Shinde, R.V. Shejawal, T.V. Kolekar, S.R. Bamane, enhanced hemolytic biocompatibility of hydroxyapatite by chromium (Cr3+) doping in hydroxyapatite nanoparticles synthesized by solution combustion method. J. Korean Ceram. Soc. 54, 158–166 (2017)
A.V. Singh, M. Varma, P. Laux, Artificial intelligence and machine learning disciplines with the potential to improve the nanotoxicology and nanomedicine fields: a comprehensive review. Arch. Toxicol. 97, 963–979 (2023)
R. Reedad, P. Prayongpan, W. Busayaporn, K. Songsrirote, Synthesis and application of optical silver nanoparticles capped carbon dots as dual-mode sensors for trivalent chromium ions in dietary supplements. Sens. Int. 5, 100281 (2024)
A. Swaroop, M. Bagchi, H.G. Preuss, S. Zafra-Stone, T. Ahmad, D. Bagchi, Benefits of chromium(III) complexes in animal and human health, in The Nutritional Biochemistry of Chromium (III). (Elsevier, Amsterdam, 2019), pp.251–278
M.K. Murthy, P. Khandayataray, S. Padhiary, D. Samal, A review on chromium health hazards and molecular mechanism of chromium bioremediation. Rev. Environ. Health (2022). https://doi.org/10.1515/reveh-2021-0139
P. Sharma, S.P. Singh, S.K. Parakh, Y.W. Tong, Health hazards of hexavalent chromium (Cr (VI)) and its microbial reduction. Bioengineered (2022). https://doi.org/10.1080/21655979.2022.2037273
V.J. Huerta, P. Fernández, V. Gómez, O.A. Graeve, M. Herrera, Defect-related luminescence properties of hydroxyapatite nanobelts. Appl. Mater. Today 21, 100822 (2020)
E.O. López, P.L. Bernardo, N.R. Checca, A.L. Rossi, A. Mello, D.E. Ellis, A.M.R. Rossi, J. Terra, Hydroxyapatite and lead-substituted hydroxyapatite near-surface structures: novel modelling of photoemission lines from X-ray photoelectron spectra. Appl. Surf. Sci. 571, 151310 (2022)
A.V. Singh, M.H. Dad Ansari, C.B. Dayan, J. Giltinan, S. Wang, Y. Yu, V. Kishore, P. Laux, A. Luch, M. Sitti, Multifunctional magnetic hairbot for untethered osteogenesis, ultrasound contrast imaging and drug delivery. Biomaterials 219, 119394 (2019)
O.A. Graeve, R. Kanakala, A. Madadi, B.C. Williams, K.C. Glass, Luminescence variations in hydroxyapatites doped with Eu2+ and Eu3+ ions. Biomaterials 31, 4259–4267 (2010)
X. Li, J. Cao, W. Zhang, Stoichiometry of Cr(VI) Immobilization Using Nanoscale Zerovalent Iron (nZVI): a study with High-Resolution X-Ray Photoelectron Spectroscopy (HR-XPS). Ind. Eng. Chem. Res. 47, 2131 (2008)
S. Kačiulis, G. Mattogno, L. Pandolfi, M. Cavalli, G. Gnappi, A. Montenero, XPS study of apatite-based coatings prepared by sol–gel technique. Appl. Surf. Sci. 151, 1–5 (1999)
R.J. Chung, M.F. Hsieh, R.N. Panda, T.S. Chin, Hydroxyapatite layers deposited from aqueous solutions on hydrophilic silicon substrate. Surf. Coat. Technol. 165, 194–200 (2003)
H.Y. Shin, J.Y. Jung, S.W. Kim, W.K. Lee, XPS Analysis on chemical properties of calcium phosphate thin films and osteoblastic HOS cell responses. J. Ind. Eng. Chem. 12, 476–483 (2006)
C.D. Wagner, A.V. Naumki, A. Kraut-Vass, J.W. Allison, C.J. Powell, J.R. Rumble, NIST Standard Reference Database 20. Web version 3.4. http/srdata.nist.gov/xps/
M.C. Biesinger, B.P. Payne, A.P. Grosvenor, L.W.M. Lau, A.R. Gerson, R.S.C. Smart, Resolving surface chemical states in XPS analysis of first row transition metals, oxides and hydroxides: Cr, Mn, Fe Co and Ni. Appl. Surf. Sci. 257, 2717–2730 (2011)
T.A.R.M. Lima, N.S. Brito, J.A. Peixoto, M.E.G. Valerio, The incorporation of chromium (III) into hydroxyapatite crystals. Mater. Lett. 140, 187–191 (2015)
P.N. De Aza, F. Guitián, C. Santos, S. De Aza, R. Cuscó, L. Artús, Vibrational properties of calcium phosphate compounds. 2. Comparison between hydroxyapatite and β-tricalcium phosphate. Chem. Mater. 9, 916–922 (1997)
J.A. Darr, Z.X. Guo, V. Raman, M. Bououdina, I.U. Rehman, Metal organic chemical vapour deposition (MOCVD) of bone mineral like carbonated hydroxyapatite coatings. Chem. Commun. 10, 696–697 (2004)
R. Cuscó, F. Guitiqh, S. De Azac, L. Arttis, Differentiation between hydroxyapatite and β-tricalcium phosphate by means of μ-Raman spectroscopy. J. Eur. Ceram. Soc. 18(9), 1301–1305 (1998)
S. Gomes, J.M. Nedelec, E. Jallot, D. Sheptyakov, G. Renaudin, Unexpected mechanism of Zn2+ insertion in calcium phosphate bioceramics. Chem. Mater. 23, 3072–3085 (2011)
V.S. Bystrov, C. Piccirillo, D.M. Tobaldi, P.M.L. Castro, J. Coutinho, S. Kopyl, R.C. Pullar, Oxygen vacancies, the optical band gap (Eg) and photocatalysis of hydroxyapatite: comparing modelling with measured data. Appl. Catal. B Environ. 196, 100–107 (2016)
K. Matsunaga, A. Kuwabara, First-principles study of vacancy formation in hydroxyapatite. Phys. Rev. B 75, 14102 (2007)
V.S. Bystrov, E.V. Paramonova, L.A. Avakyan, J. Coutinho, N. Bulina, Simulation and computer study of structures and physical properties of hydroxyapatite with various defects. Nanomaterial 11, 2752 (2021)
V.S. Bystrov, L.A. Avakyan, E.V. Paramonova, J. Coutinho, Sub-band gap absorption mechanisms involving oxygen vacancies in hydroxyapatite. J. Phys. Chem. C 123, 4856–4865 (2019)
V.S. Chandra, G. Baskar, R.V. Suganthi, K. Elayaraja, M.I.A. Joshy, W. Sofi Beaula, R. Mythili, G. Venkatraman, S. Narayana-Kalkura, Blood compatibility of iron-doped nanosize hydroxyapatite and its drug release. ACS Appl. Mater. Interfaces 4, 1200–1210 (2012)
V. Iannotti, A. Adamiano, G. Ausanio, L. Lanotte, G. Aquilanti, J.M.D. Coey, M. Lantieri, G. Spina, M. Fittipaldi, G. Margaris, K. Trohidou, S. Sprio, M. Montesi, S. Panseri, M. Sandri, M. Iafisco, A. Tampieri, Fe-doping-induced magnetism in nano-hydroxyapatites. Inorg. Chem. 56, 4446–4458 (2017)
K.C. Kao, Dielectric Phenomena in Solids (Elsevier, Amsterdam, 2004), pp.1–39
M. Curcio, J.V. Rau, A. Santagata, R. Teghil, S. Laureti, A. De Bonis, Laser synthesis of iron nanoparticle for Fe doped hydroxyapatite coatings. Mater. Chem. Phys. 225, 365–370 (2019)
Acknowledgements
This work was supported by grants from the National Science Foundation (No. 1911372), the UC-MEXUS program (No. CN19-137), and DGAPA (No. IN104724). KC is grateful to CONACYT for a graduate research fellowship (No. 706781). Technical support of D. Domínguez, C. Santillan, C. Ornelas, and R. Gómez is greatly appreciated. The work has also been partially supported by Complutense University-Comunidad de Madrid via project PR65/19-22464.
Author information
Authors and Affiliations
Corresponding authors
Ethics declarations
Competing Interests
The authors declare no competing interests.
Informed Consent
On behalf of all authors, the corresponding author states that informed consent was obtained from all participants involved in the study. In addition, the corresponding authors affirm that human and animal rights were upheld in the study.
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Carrera, K., Huerta, V., Orozco, V. et al. Formation of Oxygen Vacancies in Cr3+-Doped Hydroxyapatite Nanofibers and Their Role in Generating Paramagnetism. Biomedical Materials & Devices (2024). https://doi.org/10.1007/s44174-024-00191-3
Received:
Accepted:
Published:
DOI: https://doi.org/10.1007/s44174-024-00191-3